| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK93964ADK96493D0 (da) | 1993-08-26 | 1993-08-26 | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
| EP94926106AEP0752886B1 (en) | 1993-08-26 | 1994-08-25 | Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| PCT/DK1994/000318WO1995005849A1 (en) | 1993-08-26 | 1994-08-25 | Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| AU76080/94AAU7608094A (en) | 1993-08-26 | 1994-08-25 | Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| DK94926106.9TDK0752886T3 (da) | 1993-08-26 | 1994-08-25 | Induktion af antistofsvar mod selv-proteiner ved hjælp af fremmede T-celleepitoper |
| KR1019960701052AKR100308444B1 (ko) | 1993-08-26 | 1994-08-25 | 이종 t-세포 에피토우프를 사용하여 자가 단백질에 대해항체반응을유도하는방법 |
| AT94926106TATE162723T1 (de) | 1993-08-26 | 1994-08-25 | Die induktion der antikörperantwort gegen eigene proteine mit hilfe fremder t-zellepitope |
| DE69408342TDE69408342T2 (de) | 1993-08-26 | 1994-08-25 | Die induktion der antikörperantwort gegen eigene proteine mit hilfe fremder t-zellepitope |
| ES94926106TES2112559T3 (es) | 1993-08-26 | 1994-08-25 | Induccion de respuesta de anticuerpos contra proteinas endogenas con ayuda de epitopes de celulas t extrañas. |
| JP50727895AJP3825041B2 (ja) | 1993-08-26 | 1994-08-25 | 外来ｔ−細胞エピトープを補助として用いた、自己タンパク質に対する抗体応答の誘発 |
| CA002170236ACA2170236C (en) | 1993-08-26 | 1994-08-25 | Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| US08/955,373US20020090379A1 (en) | 1993-08-26 | 1997-10-21 | Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| GR980400609TGR3026419T3 (en) | 1993-08-26 | 1998-03-20 | Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| AU70091/98AAU707083B2 (en) | 1993-08-26 | 1998-06-11 | Inducing antibody response against self-proteins with the aid of foreign T-cell epitopes |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK93964ADK96493D0 (da) | 1993-08-26 | 1993-08-26 | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
| Publication Number | Publication Date |
|---|---|
| DK96493D0true DK96493D0 (da) | 1993-08-26 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93964ADK96493D0 (da) | 1993-08-26 | 1993-08-26 | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
| DK94926106.9TDK0752886T3 (da) | 1993-08-26 | 1994-08-25 | Induktion af antistofsvar mod selv-proteiner ved hjælp af fremmede T-celleepitoper |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94926106.9TDK0752886T3 (da) | 1993-08-26 | 1994-08-25 | Induktion af antistofsvar mod selv-proteiner ved hjælp af fremmede T-celleepitoper |
| Country | Link |
|---|---|
| US (1) | US20020090379A1 (da) |
| EP (1) | EP0752886B1 (da) |
| JP (1) | JP3825041B2 (da) |
| KR (1) | KR100308444B1 (da) |
| AT (1) | ATE162723T1 (da) |
| AU (1) | AU7608094A (da) |
| CA (1) | CA2170236C (da) |
| DE (1) | DE69408342T2 (da) |
| DK (2) | DK96493D0 (da) |
| ES (1) | ES2112559T3 (da) |
| GR (1) | GR3026419T3 (da) |
| WO (1) | WO1995005849A1 (da) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410022B1 (en) | 1995-05-01 | 2002-06-25 | Avant Immunotherapeutics, Inc. | Modulation of cholesteryl ester transfer protein (CETP) activity |
| WO1996039168A1 (en) | 1995-06-06 | 1996-12-12 | The Immune Response Corporation | Method for increasing hdl cholesterol level |
| WO1997021728A1 (en) | 1995-12-12 | 1997-06-19 | Karolinska Innovations Ab | PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b) |
| AU743400B2 (en)* | 1997-04-15 | 2002-01-24 | Pharmexa A/S | Modified TNFalpha molecules, DNA encoding such modified TNFalpha molecules and vaccines comprising such modified TNFalpha molecules and DNA |
| US6319503B1 (en)* | 1998-02-19 | 2001-11-20 | Proteinix Company | Heat shock fusion-based vaccine system |
| US7588766B1 (en) | 2000-05-26 | 2009-09-15 | Elan Pharma International Limited | Treatment of amyloidogenic disease |
| US6913745B1 (en) | 1997-12-02 | 2005-07-05 | Neuralab Limited | Passive immunization of Alzheimer's disease |
| TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| US7179892B2 (en) | 2000-12-06 | 2007-02-20 | Neuralab Limited | Humanized antibodies that recognize beta amyloid peptide |
| US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
| US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
| US6743427B1 (en) | 1997-12-02 | 2004-06-01 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
| US6936249B1 (en)* | 1998-04-15 | 2005-08-30 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
| US6838269B1 (en) | 1998-04-15 | 2005-01-04 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
| SI1114166T1 (en)* | 1998-09-15 | 2005-10-31 | Pharmexa A/S | Method for down-regulating osteoprotegerin ligand activity |
| HK1040261A1 (zh)* | 1998-09-15 | 2002-05-31 | 法麦克萨有限公司 | 负调节osteoprotegerin配体活性的方法 |
| ATE269100T1 (de) | 1998-10-05 | 2004-07-15 | Pharmexa As | Verfahren zur therapeutischen impfung |
| DK1117421T3 (da)* | 1998-10-05 | 2004-11-01 | Pharmexa As | Hidtil ukendte fremgangsmåder til terapuetisk vaccination |
| ATE314095T1 (de) | 1998-10-21 | 2006-01-15 | Us Health | Virusähnliche partikel zur induktion von autoantikörpern |
| US6913749B2 (en) | 1998-11-02 | 2005-07-05 | Resistentia Pharmaceuticals Ab | Immunogenic polypeptides for inducing anti-self IgE responses |
| TR200103046T2 (tr)* | 1999-04-23 | 2002-06-21 | Pharmexa A/S | IL5 aktivitesini düşürmek için yöntem. |
| US7060670B1 (en) | 1999-05-05 | 2006-06-13 | Neurochem (International) Limited | Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| WO2000067777A1 (en)* | 1999-05-07 | 2000-11-16 | Biofan Pty Ltd | A method of prophylaxis and treatment and agents useful therefor |
| US7070784B1 (en) | 1999-07-20 | 2006-07-04 | Pharmexa A/S | Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues |
| AU783144B2 (en) | 2000-02-21 | 2005-09-29 | H. Lundbeck A/S | Novel method for down-regulation of amyloid |
| MEP30408A (en)* | 2000-02-21 | 2010-10-10 | Pharmexa As | Novel method for down-regulation of amyloid |
| AU2001285721A1 (en)* | 2000-09-06 | 2002-03-22 | Pharmexa A/S | Method for down-regulating IgE |
| AU3941002A (en) | 2000-10-31 | 2002-06-03 | Zycos Inc | Cyp1b1 nucleic acids and methods of use |
| PE20020574A1 (es) | 2000-12-06 | 2002-07-02 | Wyeth Corp | Anticuerpos humanizados que reconocen el peptido amiloideo beta |
| US7097837B2 (en) | 2001-02-19 | 2006-08-29 | Pharmexa A/S | Synthetic vaccine agents |
| US20030166589A1 (en)* | 2001-06-05 | 2003-09-04 | Nathan Karin | Method and pharmaceutical composition for the treatment of multiple sclerosis |
| MY144532A (en) | 2001-08-20 | 2011-09-30 | Lundbeck & Co As H | Novel method for down-regulation of amyloid |
| CA2467052A1 (en)* | 2001-11-16 | 2003-05-22 | Pharmexa A/S | Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts |
| WO2003075951A2 (en)* | 2002-03-11 | 2003-09-18 | Pharmexa A/S | Novel application of vaccination against tnf-alpha |
| MY139983A (en) | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
| JP2005529187A (ja) | 2002-06-13 | 2005-09-29 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 同種抗原の特定方法、ならびに癌治療および移植へのその使用 |
| WO2004052930A2 (en)* | 2002-12-11 | 2004-06-24 | Pharmexa A/S | Targeting single epitopes |
| WO2005025613A1 (en)* | 2003-03-12 | 2005-03-24 | Rappaport Family Institute For Research In The Medical Sciences | Methods of identifying biomolecular targets for diagnosis and therapy |
| WO2004080273A2 (en)* | 2003-03-12 | 2004-09-23 | Rappaport Family Institute For Research In The Medical Sciences | Compositions and methods for diagnosing and treating prostate cancer |
| US8017113B2 (en) | 2003-03-12 | 2011-09-13 | Rappaport Family Institute For Research In The Medical Sciences | Compositions and methods for diagnosing and treating an inflammation |
| WO2004085477A1 (en)* | 2003-03-28 | 2004-10-07 | Innogenetics N.V. | Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity |
| EA008827B1 (ru) | 2003-06-25 | 2007-08-31 | Фармекса А/С | Очистка вариантов her-2 |
| JP4751984B2 (ja)* | 2004-09-27 | 2011-08-17 | 順 西平 | Ｄｎａワクチン |
| WO2006066049A2 (en) | 2004-12-15 | 2006-06-22 | Neuralab Limited | Humanized antibodies that recognize beta amyloid peptide |
| EP1838348B1 (en) | 2004-12-15 | 2013-06-26 | Janssen Alzheimer Immunotherapy | Humanized amyloid beta antibodies for use in improving cognition |
| CN101222941A (zh)* | 2005-05-24 | 2008-07-16 | 尼奥瓦克斯公司 | 用于制备包含TNFα和载体蛋白质的抗原杂络物的稳定的免疫原产品的方法 |
| EP1957534A1 (en)* | 2005-11-09 | 2008-08-20 | Pharmexa A/S | Therapeutic vaccines targeting hmgb1 |
| US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
| WO2007137586A2 (en)* | 2006-05-31 | 2007-12-06 | Pharmexa A/S | Random insertion of peptides |
| AU2007307080B2 (en) | 2006-10-06 | 2014-01-09 | Bavarian Nordic A/S | Methods for treating cancer with MVA |
| US8053231B2 (en) | 2007-04-03 | 2011-11-08 | Jun Nishihira | DNA vaccine |
| US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
| PL2182983T3 (pl) | 2007-07-27 | 2014-10-31 | Janssen Alzheimer Immunotherap | Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta |
| JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
| US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
| SE535982C2 (sv)* | 2009-12-15 | 2013-03-19 | Theravac Pharmaceuticals Ab | Ett nytt vaccin som angriper tumörkärl som ett effektivt redskap i tumörterapi |
| CN105705522B (zh)* | 2013-05-14 | 2020-09-15 | 上海亨臻实业有限公司 | 针对低免疫原性蛋白的表位疫苗及其制法和用途 |
| JP2024505525A (ja)* | 2021-01-29 | 2024-02-06 | エランコ アニマル ヘルス ゲー・エム・ベー・ハー | 自己寛容を破壊するためのワクチン組成物 |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0108146B1 (en)* | 1982-05-12 | 1987-01-28 | The President And Fellows Of Harvard College | Fused genes encoding hybrid proteins, cloning vectors containing them and the use thereof |
| US4684623A (en)* | 1985-05-02 | 1987-08-04 | The Board Of Trustees Of The Cetus Corporation | Use of tumor necrosis factor as a weight regulator |
| US4772685A (en)* | 1985-10-02 | 1988-09-20 | Merck & Co., Inc. | Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies |
| US5126399A (en)* | 1986-04-30 | 1992-06-30 | Board Of Regents, The University Of Texas System | Methods and compositions for the preparation and use of site-directed immunologic reagents |
| EP0269455A3 (en)* | 1986-11-28 | 1989-09-06 | Takeda Chemical Industries, Ltd. | Highly purified fused protein comprising human ige fc fragment and production thereof |
| NL8700927A (nl)* | 1987-04-16 | 1988-11-16 | Stichting Rega V Z W | Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing. |
| GB8812214D0 (en)* | 1988-05-24 | 1988-06-29 | Hoffmann La Roche | Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope |
| WO1989012458A1 (en)* | 1988-06-14 | 1989-12-28 | Cell Med, Inc. | Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| US5260422A (en)* | 1988-06-23 | 1993-11-09 | Anergen, Inc. | MHC conjugates useful in ameliorating autoimmunity |
| ES2082850T3 (es)* | 1989-02-24 | 1996-04-01 | Univ California | Inmunoglobulinas preparadas geneticamente. |
| GB8905400D0 (en)* | 1989-03-09 | 1989-04-19 | Jonker Margreet | Medicaments |
| MY105946A (en)* | 1989-07-14 | 1995-02-28 | Schering Corp | Antagonists of gm-csf derived from the carboxyl terminus. |
| IT1231727B (it)* | 1989-08-11 | 1991-12-21 | Enrico Savoldi | Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone. |
| US5969109A (en)* | 1990-02-28 | 1999-10-19 | Bona; Constantin | Chimeric antibodies comprising antigen binding sites and B and T cell epitopes |
| CH683101A5 (de)* | 1990-09-18 | 1994-01-14 | Biotech Australia Pty Ltd | T-Zellen-Epitope. |
| US5698195A (en)* | 1991-03-18 | 1997-12-16 | New York University Medical Center | Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies |
| AU634379B2 (en)* | 1991-04-29 | 1993-02-18 | Csl Limited | Recombinant immunocastration vaccine |
| US6419931B1 (en)* | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
| SE9102808L (sv)* | 1991-09-26 | 1993-03-27 | Lars T Hellman Inst F Immunolo | Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner |
| AU4377793A (en)* | 1992-05-20 | 1993-12-13 | Johns Hopkins University, The | Alternative receptor therapy |
| US5716596A (en)* | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
| Publication number | Publication date |
|---|---|
| US20020090379A1 (en) | 2002-07-11 |
| GR3026419T3 (en) | 1998-06-30 |
| KR100308444B1 (ko) | 2001-11-30 |
| CA2170236A1 (en) | 1995-03-02 |
| JPH09505031A (ja) | 1997-05-20 |
| DE69408342D1 (de) | 1998-03-05 |
| JP3825041B2 (ja) | 2006-09-20 |
| DK0752886T3 (da) | 1998-05-04 |
| DE69408342T2 (de) | 1998-05-14 |
| WO1995005849A1 (en) | 1995-03-02 |
| ES2112559T3 (es) | 1998-04-01 |
| ATE162723T1 (de) | 1998-02-15 |
| EP0752886A1 (en) | 1997-01-15 |
| KR960704568A (ko) | 1996-10-09 |
| CA2170236C (en) | 2007-11-06 |
| AU7608094A (en) | 1995-03-21 |
| EP0752886B1 (en) | 1998-01-28 |
| Publication | Publication Date | Title |
|---|---|---|
| DK96493D0 (da) | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden | |
| RU2363707C2 (ru) | Искусственные белки с пониженной иммуногенностью | |
| DK1203817T3 (da) | Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose | |
| NO991694L (no) | Forbindelser og metoder for immunoterapi og diagnose av tuberkulose | |
| ATE229978T1 (de) | Helicobacter proteine und impstoffe | |
| EP2311952A3 (en) | Antibodies to MRT-1 protein or fragments thereof | |
| NO20075902L (no) | Forbindelser for immunoterapi og diagnose av turberkolose og metoder for deres anvendelse | |
| AR052377A2 (es) | Polipeptidos y polinucleotidos de neisseria meningitidis, un huesped unicelular, un metodo para producir una secuencia de adn, un metodo para producir un polipeptido, un metodo para aislar el antigeno, una composicion farmaceutica, uso de una proteina para producir una vacuna destinada para la preve | |
| DK0469045T3 (da) | Syntetiske Pseudomonas aeruginosa pilinpeptider og beslægtede vacciner diagnostica | |
| NO984244L (no) | Vaksinesammensetninger og fremgangsmÕter som er nyttige i Õ indusere immunbeskyttelse mot artritogene peptider som er involvert i patogenese av reumatoid artritt | |
| AU707083B2 (en) | Inducing antibody response against self-proteins with the aid of foreign T-cell epitopes | |
| DK0701612T3 (da) | Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremsti | |
| ATE109512T1 (de) | Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind. | |
| DE69520943D1 (de) | Malariapeptide | |
| MY105080A (en) | Heat-labile toxin b subunit fusion proteins. | |
| SE9001105D0 (sv) | New methods foer diagnosis of tuberculosis | |
| DK0687300T3 (da) | LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation | |
| ES8800052A1 (es) | Un procedimiento para preparar una proteina de superficie antigenica de anaplasma marginale | |
| DE69432730D1 (de) | Rekombinante Adenovirus-Vakzinen | |
| EP0879244A4 (en) | RECOMBINANT POLYPEPTIDE VACCINE AGAINST MYCOPLASMS. | |
| Yamabe et al. | Antigenic group II chaperonin in Methanobrevibacter oralis may cross‐react with human chaperonin CCT | |
| WO2000039301A3 (en) | Methods for using mycobacterium tuberculosis molecules as immunological adjuvants | |
| Mountford et al. | Fractionation of schistosome antigens by high performance electrophoretic chromatography and their screening for the ability to induce Th1 lymphocyte activity | |
| DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
| DK43991A (da) | Allele varianter af plasmodium falciparum merozoitoverfladeantigen |
| Date | Code | Title | Description |
|---|---|---|---|
| A0 | Application filed | ||
| AHS | Application shelved for other reasons than non-payment |